Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study (vol 27, pg 329, 2009)

被引：0
|
作者：
Pizzi, L. T.
Talati, A.
Gemmen, E.
Dahl, N., V
Bunz, T. J.
Sand, P. K.
机构：
[1] Jefferson School of Population Health,Doris N. Grandon Center for Health Economics and Outcomes Research
[2] Jefferson School of Population Health,Evanston Continence Center
[3] Quintiles,undefined
[4] Watson Laboratories,undefined
[5] Inc.,undefined
[6] Northwestern University,undefined
[7] Feinberg School of Medicine,undefined
来源：
PHARMACOECONOMICS | 2012年 / 30卷 / 06期
关键词：
D O I：
10.2165/11633660-000000000-00000
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：534 / 535
页数：2
相关论文
共 50 条
  • [1] Impact of Transdermal Oxybutynin on Work Productivity in Patients with Overactive Bladder Results from the MATRIX Study
    Pizzi, Laura T.
    Talati, Amy
    Gemmen, Eric
    Dahl, Naomi V.
    Bunz, Thomas J.
    Sand, Peter K.
    PHARMACOECONOMICS, 2009, 27 (04) : 329 - 339
  • [2] Erratum to Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study
    Laura T. Pizzi
    Amy Talati
    Eric Gemmen
    Naomi V. Dahl
    Thomas J. Bunz
    Peter K. Sand
    PharmacoEconomics, 2012, 30 : 534 - 535
  • [3] Impact of Transdermal Oxybutynin on Work Productivity in Patients with Overactive BladderResults from the MATRIX Study
    Laura T. Pizzi
    Amy Talati
    Eric Gemmen
    Naomi V. Dahl
    Thomas J. Bunz
    Peter K. Sand
    PharmacoEconomics, 2009, 27 : 329 - 339
  • [4] Impact of transdermal oxybutynin on quality of life in patients with overactive bladder - Results from the MATRIX study
    Lucente, Vincent R.
    Goldberg, Roger P.
    Davila, Willy
    Gonick, Charles W.
    Parker, Robert Lamar
    Dahl, Naomi V.
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (04): : 74S - 75S
  • [5] Impact of transdermal oxybutynin on depression symptoms in patients with overactive bladder - Results of the MATRIX study
    Sand, Peter K.
    Lucente, Vincent R.
    Parker, Robert Lamar
    Goldberg, Roger P.
    Dahl, Naomi V.
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (04): : 76S - 76S
  • [6] Transdermal oxybutynin with an educational intervention for overactive bladder -: Impact on work productivity
    Sand, Peter K.
    Pizzi, Laura T.
    Dahl, Naomi V.
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (04): : 126S - 126S
  • [7] Impact of transdermal oxybutynin on nocturia and related symptoms in overactive bladder -: Results from MATRIX study
    Willy Davila, G.
    Sand, Peter K.
    Gonick, Charles W.
    Parker, Robert Lamar
    Dahl, Naomi V.
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (04): : 76S - 76S
  • [8] Work productivity in patients with overactive bladder: Results from the MATRIX study
    Talati, AR
    Pizzi, LT
    Dahl, N
    Gemmen, E
    VALUE IN HEALTH, 2006, 9 (03) : A99 - A99
  • [9] Safety of transdermal oxybutynin in the treatment of overactive bladder among patients using other transdermal medications: Results of the matrix study.
    Pizzi, L. T.
    McIlwain, M.
    Dahl, N. V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S105 - S105
  • [10] Quality of life and safety with transdermal oxybutynin in patients 85 years and older with overactive bladder: Results from the MATRIX study.
    Hamad, RA
    Dmochowski, RR
    Dahl, NV
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S71 - S72
12345